The longer you treat, the better the benefit: lessons from PCSK9 inhibitors trials - PACE-CME

The longer you treat the better the benefit lessons from PCSK inhibitors trials

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

E-counselling improves adherence in hypertensives
E-counselling improves adherence in hypertensives
ACC.17
E-counselling improves adherence in hypertensives
- Dr. Rob Nolan
Troponin is an independent predictor of CV events at non-cardiac surgery
Troponin is an independent predictor of CV events at non-cardiac surgery
ACC.17
Troponin is an independent predictor of CV events at non-cardiac surgery
- Dr. P.J. Devereaux
The implications of PCSK9 outcome trials for GPs
The implications of PCSK9 outcome trials for GPs
ACC.17
The implications of PCSK9 outcome trials for GPs
- Prof. Richard Hobbs, MD
Identification of patients who will benefit is important after FOURIER
Identification of patients who will benefit is important after FOURIER
ACC.17
Identification of patients who will benefit is important after FOURIER
- Prof. Ulf Landmesser